Sponsor or institution

Clinical trials and research at Mabwell (Shanghai) Bioscience Co., Ltd.

• 16Clinical trials
• 1New in 30 days
• 2Countries

Newest trials

All recruiting trials (16)

• 6MW5311 in adults with relapsed or refractory blood cancers

  This study tests increasing doses of 6MW5311 in adults with multiple myeloma, AML, or CMML to see if it is safe and tolerable and to find a suitable dose for later studies.

  Recruiting Phase 1 Mabwell (Shanghai) Bioscience Co., Ltd. · Shanghai, Shanghai Municipality · NCT07914556

• Phase II test of 9MW3811 for pathological scars

  This trial will try injections of 9MW3811 to see if they improve pathological scars in adults compared with placebo.

  Recruiting Phase 2 Mabwell (Shanghai) Bioscience Co., Ltd. · Shanghai, Shanghai Municipality · NCT07576608

• 7MW3711 plus JS207 for advanced solid tumors

  This trial tests whether combining the experimental drugs 7MW3711 and JS207, with or without platinum chemotherapy, can help adults with advanced or metastatic solid tumors that have progressed after standard treatments.

  Recruiting Phase 1/2 Mabwell (Shanghai) Bioscience Co., Ltd. · Shanghai, Shanghai Municipality · NCT07466160

• Combining 9MW2821 with toripalimab around surgery for urothelial cancer

  This trial tests whether giving 9MW2821 together with toripalimab before and after surgery helps adults with non-metastatic urothelial cancer.

  Recruiting Phase 2 Mabwell (Shanghai) Bioscience Co., Ltd. · Guangzhou, Guangdong · NCT07314723

• 9MW1911 for adults with COPD

  This trial will test whether the investigational drug 9MW1911 can reduce flare-ups and improve breathing in adults aged 40–75 with moderate-to-severe COPD and recent exacerbations.

  Recruiting at 50 sites Phase 2 Mabwell (Shanghai) Bioscience Co., Ltd. · Chizhou, Anhui and 50 other locations · NCT07292714

• First-in-human use of 7MW4911 in patients with advanced solid tumors

  This trial will test whether the experimental drug 7MW4911 is safe and shows anti-tumor activity in Chinese adults with advanced solid tumors who have progressed after prior treatments.

  Recruiting Phase 1/2 Mabwell (Shanghai) Bioscience Co., Ltd. · Shanghai, Shanghai Municipality · NCT07265622

• First human use of 7MW4911 in gastrointestinal cancer

  This study will test a new drug called 7MW4911 in adults with advanced or metastatic gastrointestinal cancers that have progressed after standard treatments.

  Recruiting at 6 sites Phase 1/2 Mabwell (Shanghai) Bioscience Co., Ltd. · Port Saint Lucie, Florida and 5 other locations · NCT07216560

• Dose-randomized bulumtatug fuvedotin for triple-negative breast cancer previously treated with antibody-drug conjugates

  This trial will test whether different doses of bulumtatug fuvedotin can help adults with recurrent or metastatic triple-negative breast cancer who have already received antibody-drug conjugates.

  Recruiting at 6 sites Phase 1 Mabwell (Shanghai) Bioscience Co., Ltd. · Duarte, California and 6 other locations · NCT06908928

• Comparing two treatments for advanced urothelial carcinoma

  This study is testing if a combination of two treatments can help people with advanced bladder cancer do better than using just one of the treatments alone.

  Recruiting at 2 sites Phase 2 Mabwell (Shanghai) Bioscience Co., Ltd. · Changsha, Hunan and 1 other locations · NCT06823427

• Testing 9MW3011 for patients with non-transfusion-dependent beta-thalassemia

  This study is testing a new drug called 9MW3011 to see if it is safe and effective for people with non-transfusion-dependent beta-thalassemia.

  Recruiting at 2 sites Phase 1 Mabwell (Shanghai) Bioscience Co., Ltd. · Nanning, Guangxi and 1 other locations · NCT06772766

• Evaluating a new treatment for Polycythemia Vera

  This study is testing a new drug for people with Polycythemia Vera who haven't had success with standard treatments to see if it's safe and effective for them.

  Recruiting at 6 sites Phase 1 Mabwell (Shanghai) Bioscience Co., Ltd. · Zhengzhou, Henan and 5 other locations · NCT06752746

• Comparing 9MW2821 to standard chemotherapy for advanced cervical cancer

  This study is testing a new treatment called 9MW2821 to see if it works better than standard chemotherapy for women with advanced cervical cancer who haven't had success with previous treatments.

  Recruiting at 2 sites Phase 3 Mabwell (Shanghai) Bioscience Co., Ltd. · Beijing and 1 other locations · NCT06692166

• Combination of 9MW2821 and Toripalimab for advanced bladder cancer

  This study is testing if a new combination of two drugs, 9MW2821 and Toripalimab, can help people with advanced bladder cancer do better than the usual chemotherapy.

  Recruiting Phase 3 Mabwell (Shanghai) Bioscience Co., Ltd. · Shanghai, Shanghai Municipality · NCT06592326

• Evaluating 9MW2821 and PD-1 Inhibitor for Advanced Triple-Negative Breast Cancer

  This study is testing a new treatment called 9MW2821, alone or with another drug, to see if it helps people with advanced triple-negative breast cancer feel better.

  Recruiting Phase 2 Mabwell (Shanghai) Bioscience Co., Ltd. · Shanghai, Shanghai Municipality · NCT06492005

• Comparing 9MW2821 to chemotherapy for advanced urothelial cancer

  This study tests if a new treatment called 9MW2821 can work better than regular chemotherapy for people with advanced bladder cancer who have already tried other therapies.

  Recruiting Phase 3 Mabwell (Shanghai) Bioscience Co., Ltd. · Shanghai, Shanghai Municipality · NCT06196736

• Combining 9MW2821 and Toripalimab for advanced urothelial cancer

  This study is testing if a new combination of two drugs, 9MW2821 and Toripalimab, can help people with advanced bladder cancer feel better and improve their treatment outcomes.

  Recruiting Phase 1/2 Mabwell (Shanghai) Bioscience Co., Ltd. · Beijing, Beijing Municipality · NCT06079112

Quick answers

How many clinical trials run by Mabwell (Shanghai) Bioscience Co., Ltd. are recruiting right now?

16, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (14 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 1: 4, Phase 1/2: 4, Phase 3: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →